Morphometric analysis of neointimal formation in murine cardiac grafts: III. Dissociation of interstitial fibrosis from neointimal formation

Transplantation

Volumn 64, Issue 8, 1997, Pages 1198-1220

  Armstrong, Arthur T ^a   Strauch, Arthur R ^a   Starling, Randall C ^b   Sedmak, Daniel D ^a   Orosz, Charles G ^a,c  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALLIUM NITRATE;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ARTERIOSCLEROSIS; ARTICLE; DISEASE ASSOCIATION; FIBROSIS; GRAFT REJECTION; HEART GRAFT; ISCHEMIA; MORPHOMETRICS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CORONARY ARTERIOSCLEROSIS; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; TIME FACTORS; TRANSPLANTATION, ISOGENEIC; TUNICA INTIMA;

EID: 0030716517     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199710270-00020     Document Type: Article

References (14)

1. Hosenpud JD, Shipley GD, Wagner CR. Cardiac allograft vasculopathy: current concepts, recent developments and future directions. J Heart Lung Transplant 1992; 11: 9.
2. Armstrong AT, Strauch AR, Starling RC, Sedmak DD, Orosz CG. Morphometric analysis of neointimal formation in murine cardiac allografts. Transplantation 1997; 63: 941.
3. Russell PS, Chase CM, Winn HJ, Colvin RB. Coronary atherosclerosis in transplanted mouse hearts. Am J Pathol 1994; 144: 260.
4. Ardehali A, Billingsley A, Laks H, et al. Experimental cardiac allograft vasculopathy in mice. J Heart Lung Transplant 1990; 12: 730.
5. Armstrong AT, Strauch AR, Starling RC, Sedmak DD, Orosz CG. Morphometric analysis of neointimal formation in murine cardiac allografts: II. Rate and location of lesion development. Transplantation 1997; 64: 322.
6. Corry R, Winn H, Ressell P. Primarily vascularized allografts of hearts in mice. Transplantation 1973; 16: 343.
7. Orosz CG, Wakely E, Bergese SD, et al. Prevention of murine cardiac allograft rejection with gallium nitrate: comparison with anti-CD4 mAb. Transplantation 1996; 61: 783.
8. Tullius SG, Tilney NL. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 1995; 59(3): 313.
9. Larsen CP, Alexander DZ, Hollenbaugh D, et al. CD40-gp39 interactions play a critical role during allograft rejection. Transplantation 1996; 61: 4.
10. Orosz CG. Local cellular immunology of experimental transplant vascular sclerosis. Clin Transpl 1996; 10(2): 100.
11. Mueller R, Krahl T, Sarvetnick N. Tissue-specific expression of interleukin-4 induces extracellular matrix accumulation and extravasation of B cells. Lab Invest 1997; 76: 117.
12. Roberts AB, Sporn MB, Assoian RK, et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sei USA 1986; 83: 4167.
13. Rowan RA, Billingham ME. Pathologic changes in the long-term transplanted heart: a morphometric study of myocardial hypertrophy, vascularity, and fibrosis. Hum Pathol 1990; 21(7): 767.
14. Tanelaar HD, Edwards WD. Pathology of cardiac transplantation: recipient hearts (chronic heart failure) and donor hearts (acute and chronic rejection). Mayo Clin Proc 1992; 67: 685.